These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36276970)

  • 1. Corrigendum: Exploration of shared gene signature with development of pre-eclampsia and cervical cancer.
    Yin T; Yin Y; Qu L
    Front Genet; 2022; 13():1037320. PubMed ID: 36276970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of shared gene signature with development of pre-eclampsia and cervical cancer.
    Yin T; Yin Y; Qu L
    Front Genet; 2022; 13():972346. PubMed ID: 36061190
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer.
    He Y; Wu Y; Liu Z; Li B; Jiang N; Xu P; Xu A
    Front Genet; 2022; 13():880633. PubMed ID: 35656317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer.
    Guo Y; Chen Q; Zhang Y; Cheng X; Cen K; Dai Y; Mai Y; Hong K
    Front Genet; 2023; 14():1217912. PubMed ID: 37292143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: WGCNA Co-Expression Network Analysis Reveals ILF3-AS1 Functions as a CeRNA to Regulate PTBP1 Expression by Sponging miR-29a in Gastric Cancer.
    Ren ZH; Shang GP; Wu K; Hu CY; Ji T
    Front Genet; 2020; 11():585190. PubMed ID: 33133169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Bovine Pre-adipocyte Adipogenesis Is Regulated by bta-miR-150 Through mTOR Signaling.
    Chen X; Raza SHA; Ma X; Wang J; Wang X; Liang C; Yang X; Mei C; Suhail SM; Zan L
    Front Genet; 2021; 12():688741. PubMed ID: 34122527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Association between
    Li S; Li X; Zhang S; Feng Y; Jia T; Zhu M; Fang L; Gong L; Dong S; Kong X; Wang Z; Sun L
    Front Genet; 2023; 14():1298000. PubMed ID: 38028599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer.
    Zhang M; Liu Y; Liu Y; Hou S; Li H; Ma Y; Wang C; Chen X
    Front Genet; 2022; 13():978493. PubMed ID: 36092866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma.
    Ye Z; Zheng M; Zeng Y; Wei S; Wang Y; Lin Z; Shu C; Xie Y; Zheng Q; Chen L
    Front Genet; 2022; 13():828664. PubMed ID: 35237303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3.
    Wu Y; Zhang B; Nong J; Alarcon Rodriguez R; Guo W; Liu Y; Zhao S; Wei R
    Front Genet; 2023; 14():1204421. PubMed ID: 37287535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma.
    Zhang S; Xiao X; Wang Y; Song T; Li C; Bao H; Liu Q; Sun G; Sun X; Su T; Fu T; Wang Y; Liang P
    Front Genet; 2022; 13():961153. PubMed ID: 36061198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma.
    Yang Y; Ye X; Zhang H; Lin Z; Fang M; Wang J; Yu Y; Hua X; Huang H; Xu W; Liu L; Lin Z
    Front Genet; 2023; 14():1146199. PubMed ID: 36798531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer.
    Su R; Jin C; Bu H; Xiang J; Zhou L; Jin C
    Front Oncol; 2022; 12():861392. PubMed ID: 35651784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
    He W; Lin G; Pan C; Li W; Shen J; Liu Y; Li H; Wu D; Lin X
    Front Genet; 2022; 13():879922. PubMed ID: 35360845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Genetic diversity, population structure, and selective signature of sheep in the northeastern Tarim Basin.
    Wang J; Suo J; Yang R; Zhang CL; Li X; Han Z; Zhou W; Liu S; Gao Q
    Front Genet; 2023; 14():1336294. PubMed ID: 38094753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Cross-Species Meta-Analysis of Transcriptomic Data in Combination With Supervised Machine Learning Models Identifies the Common Gene Signature of Lactation Process.
    Farhadian M; Rafat SA; Hasanpur K; Ebrahimi M; Ebrahimie E
    Front Genet; 2019; 10():1034. PubMed ID: 31681439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma.
    Xia Q; Shu Z; Ye T; Zhang M
    Front Genet; 2021; 12():692400. PubMed ID: 34276793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Construction of an immune-related signature for predicting the ischemic events in patients undergoing carotid endarterectomy.
    Li S; Zhang Q; Weng L; Li J
    Front Genet; 2022; 13():1104846. PubMed ID: 36685906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer.
    Zhang J; Shan B; Lin L; Dong J; Sun Q; Zhou Q; Chen J; Han X
    Front Cell Dev Biol; 2021; 9():812770. PubMed ID: 34957127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
    Chen K; Zhu S; Yu W; Xia Y; Xing J; Geng J; Cheng F
    Front Oncol; 2022; 12():908832. PubMed ID: 35600386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.